[article] 
inLancet Psychiatry (The) > Vol.8, n°1 (January 2021) . - 17-18

Titre :	Addressing in-hospital illicit substance use [Correspondence]
Type de document :	Périodique
Auteurs :	B. S. BARNETT ; N. P. MORRIS ; J. SUZUKI
Année de publication :	2021
Article en page(s) :	17-18
Langues :	Anglais (eng)
Mots-clés :	Thésaurus TOXIBASE PRODUIT ILLICITE ; HOPITAL ; CONSOMMATION ; PERSONNEL MEDICAL ; USAGER
Domaine :	Drogues illicites / Illicit drugs
Discipline :	TRA Traitement et prise en charge / Treatment and care
Résumé :	Despite the global ubiquity of illicit substance use, health professionals might not consider the difficulties, shame, and health risks associated with illicit substance use in an unexpected place: hospitals. Few studies have assessed this problem, but existing evidence suggests it frequently occurs. In a 2015 Canadian study of 1028 people who use drugs and had ever been admitted to hospital, 451 (43.9%) reported ever using illicit drugs while they were in the hospital. US studies have estimated that 34-41% of patients used illicit substances during their hospital stay for injection-related infections. [Extract]
Refs biblio. :	5
Affiliation :	Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83560

[article] Addressing in-hospital illicit substance use [Correspondence] [Périodique] / B. S. BARNETT ; N. P. MORRIS ; J. SUZUKI . - 2021 . - 17-18.
Langues : Anglais (eng)
in Lancet Psychiatry (The) > Vol.8, n°1 (January 2021) . - 17-18

Mots-clés :	Thésaurus TOXIBASE PRODUIT ILLICITE ; HOPITAL ; CONSOMMATION ; PERSONNEL MEDICAL ; USAGER
Domaine :	Drogues illicites / Illicit drugs
Discipline :	TRA Traitement et prise en charge / Treatment and care
Résumé :	Despite the global ubiquity of illicit substance use, health professionals might not consider the difficulties, shame, and health risks associated with illicit substance use in an unexpected place: hospitals. Few studies have assessed this problem, but existing evidence suggests it frequently occurs. In a 2015 Canadian study of 1028 people who use drugs and had ever been admitted to hospital, 451 (43.9%) reported ever using illicit drugs while they were in the hospital. US studies have estimated that 34-41% of patients used illicit substances during their hospital stay for injection-related infections. [Extract]
Refs biblio. :	5
Affiliation :	Department of Psychiatry and Psychology, Center for Behavioral Health, Neurological Institute, Cleveland Clinic, Cleveland, OH, USA
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83560

[article] 
inDrug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108356

Titre :	Alcohol consumption among French physicians: A cross-sectional study
Type de document :	Périodique
Auteurs :	P. C. THIEBAUD ; C. MARTIN ; D. NAOURI ; A. LE JONCOUR ; J. TRUCHOT ; Y. YORDANOV
Année de publication :	2021
Article en page(s) :	art. 108356
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique FRANCE ; ILE-DE-FRANCE Thésaurus TOXIBASE MEDECIN ; MEDECIN GENERALISTE ; MEDECIN SPECIALISTE ; PERSONNEL MEDICAL ; HOPITAL ; ALCOOL ; PREVALENCE ; USAGE PROBLEMATIQUE ; AUDIT ; MEDECINE DU TRAVAIL ; ETUDE TRANSVERSALE ; CONSOMMATION ; MILIEU PROFESSIONNEL
Domaine :	Alcool / Alcohol
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	Background: Data regarding French physicians' alcohol behaviours are scarce and most studies address this issue within the population of either medical students or residents. We aim to describe and assess the prevalence of hazardous alcohol consumption among French physicians. Methods: A regional, cross-sectional, survey was conducted in 2018 using an online questionnaire among Parisian general practitioners and hospital doctors. Hazardous alcohol consumption was defined by an Alcohol Use Disorders Identification Test (AUDIT) score >= 8. Data were analysed in 2020. Results: Five hundred fifteen physicians completed the survey: 108 general practitioners and 407 hospital physicians. The median age was 40 years [32-55] and 59% were women. They considered their physical and mental health as average or bad in 10% and 8% of cases, respectively. The prevalence of hazardous alcohol consumption was 12.6%. Among the 65 physicians with hazardous alcohol consumption, 27 (41.5%) did not considered it as risky and four (6.2%) mentioned a potentially negative impact on patients' care. Factors independently associated with hazardous alcohol consumption were illegal drugs consumption (OR 4.62 [2.05-10.37]) and fixed term contract for hospital doctors (OR 2.69 [1.14-6.36]). Conclusions: The prevalence of hazardous alcohol consumption among French physicians was 12.6%. Illegal substance users and fix-termed contract hospital doctors were more likely to have risky alcohol consumption. A large-scale national study would confirm the factors associated with hazardous alcohol consumption and could explore the efficacy of preventive measures to insure the safety and health of physicians and their patients. Highlights: • Prevalence of hazardous alcohol consumption among French physicians is 12.6%. • Drugs use and fixed term contract are associated with hazardous alcohol consumption. • Risky alcohol consumption seems similar between physicians and general population.
Affiliation :	Sorbonne Université, AP-HP, Hôpital Saint Antoine, Service d'Accueil des Urgences, Paris, France
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305214
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83563

[article] Alcohol consumption among French physicians: A cross-sectional study [Périodique] / P. C. THIEBAUD ; C. MARTIN ; D. NAOURI ; A. LE JONCOUR ; J. TRUCHOT ; Y. YORDANOV . - 2021 . - art. 108356.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108356

Mots-clés :	Thésaurus Géographique FRANCE ; ILE-DE-FRANCE Thésaurus TOXIBASE MEDECIN ; MEDECIN GENERALISTE ; MEDECIN SPECIALISTE ; PERSONNEL MEDICAL ; HOPITAL ; ALCOOL ; PREVALENCE ; USAGE PROBLEMATIQUE ; AUDIT ; MEDECINE DU TRAVAIL ; ETUDE TRANSVERSALE ; CONSOMMATION ; MILIEU PROFESSIONNEL
Domaine :	Alcool / Alcohol
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	Background: Data regarding French physicians' alcohol behaviours are scarce and most studies address this issue within the population of either medical students or residents. We aim to describe and assess the prevalence of hazardous alcohol consumption among French physicians. Methods: A regional, cross-sectional, survey was conducted in 2018 using an online questionnaire among Parisian general practitioners and hospital doctors. Hazardous alcohol consumption was defined by an Alcohol Use Disorders Identification Test (AUDIT) score >= 8. Data were analysed in 2020. Results: Five hundred fifteen physicians completed the survey: 108 general practitioners and 407 hospital physicians. The median age was 40 years [32-55] and 59% were women. They considered their physical and mental health as average or bad in 10% and 8% of cases, respectively. The prevalence of hazardous alcohol consumption was 12.6%. Among the 65 physicians with hazardous alcohol consumption, 27 (41.5%) did not considered it as risky and four (6.2%) mentioned a potentially negative impact on patients' care. Factors independently associated with hazardous alcohol consumption were illegal drugs consumption (OR 4.62 [2.05-10.37]) and fixed term contract for hospital doctors (OR 2.69 [1.14-6.36]). Conclusions: The prevalence of hazardous alcohol consumption among French physicians was 12.6%. Illegal substance users and fix-termed contract hospital doctors were more likely to have risky alcohol consumption. A large-scale national study would confirm the factors associated with hazardous alcohol consumption and could explore the efficacy of preventive measures to insure the safety and health of physicians and their patients. Highlights: • Prevalence of hazardous alcohol consumption among French physicians is 12.6%. • Drugs use and fixed term contract are associated with hazardous alcohol consumption. • Risky alcohol consumption seems similar between physicians and general population.
Affiliation :	Sorbonne Université, AP-HP, Hôpital Saint Antoine, Service d'Accueil des Urgences, Paris, France
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305214
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83563

[article] 
inAddiction > Vol.116, n°1 (January 2021) . - 139-149

Titre :	Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey
Type de document :	Périodique
Auteurs :	K. FARSALINOS ; A. BARBOUNI ; R. NIAURA
Année de publication :	2021
Article en page(s) :	139-149
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique ETATS-UNIS Thésaurus TOXIBASE ADOLESCENT ; EVOLUTION ; CIGARETTE ELECTRONIQUE ; CANNABIS ; PREVALENCE ; ETUDE TRANSVERSALE
Domaine :	Drogues illicites / Illicit drugs ; Tabac / Tobacco
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	AIMS: To examine changes from 2017 to 2018 in e-cigarette use and ever marijuana use with e-cigarettes among US adolescents. DESIGN: Analysis of data from the 2017 and 2018 National Youth Tobacco Survey (NYTS), cross-sectional surveys of US middle school (grades 6-8) and high school (grades 9-12) students. SETTING: United States. PARTICIPANTS: US adolescent population from middle school, with mean age = 12.7 [standard deviation (SD) = 1.0] years, and high school, with mean age = 16.1 (SD = 1.3) years. MEASUREMENTS: Analysis of e-cigarette use and ever use of marijuana with e-cigarettes according to frequency of use and smoking status, comparing 2017 with 2018. Frequent smoking and e-cigarette use was defined as use for >= 20 of the past 30 days. FINDINGS: Past 30 days e-cigarette use was reported by 33.1% [95% confidence interval (CI) = 29.1-37.4%] of ever/no past 30 days smokers, 68.6% (95% CI = 64.1-72.7%) of past 30 days smokers and 7.2% (95% CI = 6.3-8.2%) of never smokers in 2018 and by 19.3% (95% CI = 16.1-23.1%), 53.0% (95% CI = 46.9-58.9%) and 3.3% (95% CI = 2.7-4.4%) in 2017, respectively (all P < 0.001). Prevalence of past 30 days e-cigarette use was higher among frequent smokers (69.8%, 95% CI = 62.3-76.5% in 2018; 53.8%, 95% CI = 44.1-63.2% in 2017, P < 0.001) and lower among never smokers. Most of the latter were infrequent users, while frequent and daily e-cigarette use was 18- and 24-fold lower compared with ever smokers, respectively. Approximately half of past 30 days and 70% of frequent e-cigarette users reported ever marijuana use with e-cigarettes in both years. Past 30 days smokers were more likely to report past 30 days e-cigarette use [odds ratio (OR) = 15.79, 95% CI = 12.58-19.83 in 2018; OR = 16.11, 95% CI = 12.44-20.86 in 2017) compared with adolescents reporting no past 30 days smoking. CONCLUSIONS: Among US adolescents, e-cigarette use increased in all smoking groups in 2018 compared with 2017. Frequent and daily e-cigarette use was far lower in never-smokers compared with ever-smokers. High prevalence of ever marijuana use with e-cigarettes was observed.
Refs biblio. :	49
Affiliation :	Department of Pharmacy, University of Patras, Rio, Greece
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83585

[article] Changes from 2017 to 2018 in e-cigarette use and in ever marijuana use with e-cigarettes among US adolescents: analysis of the National Youth Tobacco Survey [Périodique] / K. FARSALINOS ; A. BARBOUNI ; R. NIAURA . - 2021 . - 139-149.
Langues : Anglais (eng)
in Addiction > Vol.116, n°1 (January 2021) . - 139-149

Mots-clés :	Thésaurus Géographique ETATS-UNIS Thésaurus TOXIBASE ADOLESCENT ; EVOLUTION ; CIGARETTE ELECTRONIQUE ; CANNABIS ; PREVALENCE ; ETUDE TRANSVERSALE
Domaine :	Drogues illicites / Illicit drugs ; Tabac / Tobacco
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	AIMS: To examine changes from 2017 to 2018 in e-cigarette use and ever marijuana use with e-cigarettes among US adolescents. DESIGN: Analysis of data from the 2017 and 2018 National Youth Tobacco Survey (NYTS), cross-sectional surveys of US middle school (grades 6-8) and high school (grades 9-12) students. SETTING: United States. PARTICIPANTS: US adolescent population from middle school, with mean age = 12.7 [standard deviation (SD) = 1.0] years, and high school, with mean age = 16.1 (SD = 1.3) years. MEASUREMENTS: Analysis of e-cigarette use and ever use of marijuana with e-cigarettes according to frequency of use and smoking status, comparing 2017 with 2018. Frequent smoking and e-cigarette use was defined as use for >= 20 of the past 30 days. FINDINGS: Past 30 days e-cigarette use was reported by 33.1% [95% confidence interval (CI) = 29.1-37.4%] of ever/no past 30 days smokers, 68.6% (95% CI = 64.1-72.7%) of past 30 days smokers and 7.2% (95% CI = 6.3-8.2%) of never smokers in 2018 and by 19.3% (95% CI = 16.1-23.1%), 53.0% (95% CI = 46.9-58.9%) and 3.3% (95% CI = 2.7-4.4%) in 2017, respectively (all P < 0.001). Prevalence of past 30 days e-cigarette use was higher among frequent smokers (69.8%, 95% CI = 62.3-76.5% in 2018; 53.8%, 95% CI = 44.1-63.2% in 2017, P < 0.001) and lower among never smokers. Most of the latter were infrequent users, while frequent and daily e-cigarette use was 18- and 24-fold lower compared with ever smokers, respectively. Approximately half of past 30 days and 70% of frequent e-cigarette users reported ever marijuana use with e-cigarettes in both years. Past 30 days smokers were more likely to report past 30 days e-cigarette use [odds ratio (OR) = 15.79, 95% CI = 12.58-19.83 in 2018; OR = 16.11, 95% CI = 12.44-20.86 in 2017) compared with adolescents reporting no past 30 days smoking. CONCLUSIONS: Among US adolescents, e-cigarette use increased in all smoking groups in 2018 compared with 2017. Frequent and daily e-cigarette use was far lower in never-smokers compared with ever-smokers. High prevalence of ever marijuana use with e-cigarettes was observed.
Refs biblio. :	49
Affiliation :	Department of Pharmacy, University of Patras, Rio, Greece
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83585

[article] 
inAddictive Behaviors > Vol.112 (January 2021) . - art. 106620

Titre :	Does how you use matter? The link between mode of use and cannabis-related risk
Type de document :	Périodique
Auteurs :	C. SWAN ; M. A. FERRO ; K. THOMPSON
Année de publication :	2021
Article en page(s) :	art. 106620
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique CANADA Thésaurus TOXIBASE CANNABIS ; JEUNE ; ADULTE JEUNE ; TYPE D'USAGE ; VOIE D'ADMINISTRATION ; FACTEUR DE RISQUE ; ALCOOL ; PREVALENCE
Domaine :	Drogues illicites / Illicit drugs
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	Objectives: With the recent legalization of cannabis there are more cannabis products available to consumers today than ever before. However, little is known about the relation of distinct modes of use to cannabis-related risks. The current study estimated the prevalence of different modes of use among a sample of university students, and quantified the magnitude of association between modes of use (type and number) and cannabis-related risks (i.e., dependence, negative consequences, simultaneous use with alcohol). Methods: The sample included 368 undergraduate students (71% female) who reported using cannabis in the last 6 months. Results: Joints were the most commonly reported primary mode (39%), followed by bongs/water pipes (33%), hand pipes (14%), edibles (7%) and vaporizers (5%). The majority of participants were multi-mode users (88%). On average, participants reported using 2.72 (sd = 1.04) modes of cannabis regularly. Bong users had more cannabis related harms (B = 1.85, p  Conclusion: Few differences in cannabis risks were found across modes of use. Frequency of use remains the most significant predictor of cannabis related risks. However, findings suggest that multimodal may be indicative of high risk cannabis use patterns and is an important target for screening and intervention. Highlights: • Joints were the most commonly reported mode of use. • Most cannabis users use multiple modes of administration. • Bong users report higher mean levels of cannabis use and related harms. • Multimodal users had more cannabis harms and misuse symptoms than single mode users.
Affiliation :	St. Francis Xavier University, Canada
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83581

[article] Does how you use matter? The link between mode of use and cannabis-related risk [Périodique] / C. SWAN ; M. A. FERRO ; K. THOMPSON . - 2021 . - art. 106620.
Langues : Anglais (eng)
in Addictive Behaviors > Vol.112 (January 2021) . - art. 106620

Mots-clés :	Thésaurus Géographique CANADA Thésaurus TOXIBASE CANNABIS ; JEUNE ; ADULTE JEUNE ; TYPE D'USAGE ; VOIE D'ADMINISTRATION ; FACTEUR DE RISQUE ; ALCOOL ; PREVALENCE
Domaine :	Drogues illicites / Illicit drugs
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	Objectives: With the recent legalization of cannabis there are more cannabis products available to consumers today than ever before. However, little is known about the relation of distinct modes of use to cannabis-related risks. The current study estimated the prevalence of different modes of use among a sample of university students, and quantified the magnitude of association between modes of use (type and number) and cannabis-related risks (i.e., dependence, negative consequences, simultaneous use with alcohol). Methods: The sample included 368 undergraduate students (71% female) who reported using cannabis in the last 6 months. Results: Joints were the most commonly reported primary mode (39%), followed by bongs/water pipes (33%), hand pipes (14%), edibles (7%) and vaporizers (5%). The majority of participants were multi-mode users (88%). On average, participants reported using 2.72 (sd = 1.04) modes of cannabis regularly. Bong users had more cannabis related harms (B = 1.85, p  Conclusion: Few differences in cannabis risks were found across modes of use. Frequency of use remains the most significant predictor of cannabis related risks. However, findings suggest that multimodal may be indicative of high risk cannabis use patterns and is an important target for screening and intervention. Highlights: • Joints were the most commonly reported mode of use. • Most cannabis users use multiple modes of administration. • Bong users report higher mean levels of cannabis use and related harms. • Multimodal users had more cannabis harms and misuse symptoms than single mode users.
Affiliation :	St. Francis Xavier University, Canada
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83581

[article] 
inDrug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108416

Titre :	Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016
Type de document :	Périodique
Auteurs :	J. N. PARK ; E. RASHIDI ; K. FOTI ; M. ZOOROB ; S. SHERMAN ; G. C. ALEXANDER
Année de publication :	2021
Article en page(s) :	art. 108416
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique ETATS-UNIS Thésaurus TOXIBASE EVOLUTION ; SAISIE ; PRODUIT ILLICITE ; FENTANYLOIDES ; MARCHE DE LA DROGUE ; SURDOSE ; ETUDE TRANSVERSALE ; METHAMPHETAMINE ; COCAINE ; ADULTERANT ; STIMULANTS
Domaine :	Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :	MAR Marché de la drogue / Drug market
Résumé :	Background: U.S. research examining the illicit drug supply remains rare even though the information could help reduce overdoses. Relatively little is known regarding how often opioids are found in stimulants and whether temporal and geographic trends exist. We examined trends in fentanyl-cocaine and fentanyl-methamphetamine combinations in the national illicit drug supply. Methods: We analysed serial cross-sectional data from the National Forensic Laboratory Information System (NFLIS) collected between January 2011 and December 2016. We restricted the analysis to cocaine (N = 1,389,968) and methamphetamine (n = 1,407,474) samples and calculated proportions containing fentanyl (including 23 related analogs) over time. Results: The combined presence of fentanyl and cocaine steadily increased nationally between 2012-2016 (p = 0.01), and the number of such samples tripled from 2015 to 2016 (n = 423 to n = 1,325). Similarly, the combined presence of fentanyl and methamphetamine increased 179% from 2015 to 2016 (n = 82 - n = 272). Patterns varied widely by state; in 2016, fentanyl-cocaine samples were most common in New Hampshire (7.2%), Connecticut (5.4%), Ohio (2.6%) and Massachusetts (2.1%), whereas fentanyl-methamphetamine samples were most often in New Hampshire (6.1%), Massachusetts (5.6%), Vermont (2.4%) and Maine (1.2%). Conclusions: Although relatively uncommon, the presence of fentanyl in the stimulant supply increased significantly between 2011 and 2016, with the greatest increases occuring between 2015-2016; the presence of these products was concentrated in the U.S. Northeast. Given these trends, strengthening community-based drug checking programs and surveillance within the public health infrastructure could help promote timely responses to novel threats posed by rapid shifts in the drug supply that may lead to inadvertent exposures. Highlights: • Fentanyl-stimulant combinations increased between 2015 and 2016 in the U.S. • The number and proportion of fentanyl-stimulant combinations varied by region. • Subpopulations of stimulant users may benefit from overdose prevention interventions.
Affiliation :	Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305810
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83565

[article] Fentanyl and fentanyl analogs in the illicit stimulant supply: Results from U.S. drug seizure data, 2011-2016 [Périodique] / J. N. PARK ; E. RASHIDI ; K. FOTI ; M. ZOOROB ; S. SHERMAN ; G. C. ALEXANDER . - 2021 . - art. 108416.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108416

Mots-clés :	Thésaurus Géographique ETATS-UNIS Thésaurus TOXIBASE EVOLUTION ; SAISIE ; PRODUIT ILLICITE ; FENTANYLOIDES ; MARCHE DE LA DROGUE ; SURDOSE ; ETUDE TRANSVERSALE ; METHAMPHETAMINE ; COCAINE ; ADULTERANT ; STIMULANTS
Domaine :	Autres substances / Other substances ; Drogues illicites / Illicit drugs
Discipline :	MAR Marché de la drogue / Drug market
Résumé :	Background: U.S. research examining the illicit drug supply remains rare even though the information could help reduce overdoses. Relatively little is known regarding how often opioids are found in stimulants and whether temporal and geographic trends exist. We examined trends in fentanyl-cocaine and fentanyl-methamphetamine combinations in the national illicit drug supply. Methods: We analysed serial cross-sectional data from the National Forensic Laboratory Information System (NFLIS) collected between January 2011 and December 2016. We restricted the analysis to cocaine (N = 1,389,968) and methamphetamine (n = 1,407,474) samples and calculated proportions containing fentanyl (including 23 related analogs) over time. Results: The combined presence of fentanyl and cocaine steadily increased nationally between 2012-2016 (p = 0.01), and the number of such samples tripled from 2015 to 2016 (n = 423 to n = 1,325). Similarly, the combined presence of fentanyl and methamphetamine increased 179% from 2015 to 2016 (n = 82 - n = 272). Patterns varied widely by state; in 2016, fentanyl-cocaine samples were most common in New Hampshire (7.2%), Connecticut (5.4%), Ohio (2.6%) and Massachusetts (2.1%), whereas fentanyl-methamphetamine samples were most often in New Hampshire (6.1%), Massachusetts (5.6%), Vermont (2.4%) and Maine (1.2%). Conclusions: Although relatively uncommon, the presence of fentanyl in the stimulant supply increased significantly between 2011 and 2016, with the greatest increases occuring between 2015-2016; the presence of these products was concentrated in the U.S. Northeast. Given these trends, strengthening community-based drug checking programs and surveillance within the public health infrastructure could help promote timely responses to novel threats posed by rapid shifts in the drug supply that may lead to inadvertent exposures. Highlights: • Fentanyl-stimulant combinations increased between 2015 and 2016 in the U.S. • The number and proportion of fentanyl-stimulant combinations varied by region. • Subpopulations of stimulant users may benefit from overdose prevention interventions.
Affiliation :	Department of Health, Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305810
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83565

[article] 
inInternational Journal of Drug Policy > Vol.87 (January 2021) . - art. 102966

Titre :	Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland
Type de document :	Périodique
Auteurs :	A. O'CARROLL ; T. DUFFIN ; J. COLLINS
Année de publication :	2021
Article en page(s) :	art. 102966
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique IRLANDE Thésaurus TOXIBASE REDUCTION DES RISQUES ; ETUDE DE CAS ; SANS ABRI ; PRODUIT ILLICITE ; METHADONE ; BENZODIAZEPINES ; NALOXONE ; LOGEMENT ; TRAITEMENT DE MAINTENANCE
Mots-clés :	épidémie
Domaine :	Drogues illicites / Illicit drugs
Discipline :	TRA Traitement et prise en charge / Treatment and care
Résumé :	Dublin appears to have performed very well as compared to various scenarios for COVID-19 mortality amongst homeless and drug using populations. The experience, if borne out by further research, provides important lessons for policy discussions on the pandemic, as well as broader lessons about pragmatic responses to these key client groups irrespective of COVID-19. The overarching lesson seems that when government policy is well coordinated and underpinned by a science-driven and fundamentally pragmatic approach, morbidity and mortality can be reduced. Within this, the importance of strategic clarity and delivery, housing, lowered thresholds to methadone provision, Benzodiazepine (BZD) provision and Naloxone availability were key determinants of policy success. Further, this paper argues that the rapid collapse in policy barriers to these interventions that COVID-19 produced should be secured and protected while further research is conducted.
Affiliation :	COVID-19 Clinical Lead for Homelessness in Dublin, Grangegorman Upper, Arran Quay, Dublin, Ireland
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83591

[article] Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland [Périodique] / A. O'CARROLL ; T. DUFFIN ; J. COLLINS . - 2021 . - art. 102966.
Langues : Anglais (eng)
in International Journal of Drug Policy > Vol.87 (January 2021) . - art. 102966

Mots-clés :	Thésaurus Géographique IRLANDE Thésaurus TOXIBASE REDUCTION DES RISQUES ; ETUDE DE CAS ; SANS ABRI ; PRODUIT ILLICITE ; METHADONE ; BENZODIAZEPINES ; NALOXONE ; LOGEMENT ; TRAITEMENT DE MAINTENANCE
Mots-clés :	épidémie
Domaine :	Drogues illicites / Illicit drugs
Discipline :	TRA Traitement et prise en charge / Treatment and care
Résumé :	Dublin appears to have performed very well as compared to various scenarios for COVID-19 mortality amongst homeless and drug using populations. The experience, if borne out by further research, provides important lessons for policy discussions on the pandemic, as well as broader lessons about pragmatic responses to these key client groups irrespective of COVID-19. The overarching lesson seems that when government policy is well coordinated and underpinned by a science-driven and fundamentally pragmatic approach, morbidity and mortality can be reduced. Within this, the importance of strategic clarity and delivery, housing, lowered thresholds to methadone provision, Benzodiazepine (BZD) provision and Naloxone availability were key determinants of policy success. Further, this paper argues that the rapid collapse in policy barriers to these interventions that COVID-19 produced should be secured and protected while further research is conducted.
Affiliation :	COVID-19 Clinical Lead for Homelessness in Dublin, Grangegorman Upper, Arran Quay, Dublin, Ireland
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83591

[article] 
inInternational Journal of Drug Policy > Vol.87 (January 2021) . - art. 102992

Titre :	Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study
Type de document :	Périodique
Auteurs :	P. ROUX ; C. DONADILLE ; C. MAGEN ; E. SCHATZ ; R. STRANZ ; A. CURADO ; T. TSIAKOU ; L. VERDES ; A. ALEKSOVA ; P. CARRIERI ; S. MEZAACHE ; A. BEN CHARIF
Année de publication :	2021
Article en page(s) :	art. 102992
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique EUROPE ; BULGARIE ; GRECE ; PORTUGAL ; ROUMANIE Thésaurus TOXIBASE INJECTION ; INTERVENTION ; REDUCTION DES RISQUES ; EDUCATION POUR LA SANTE ; PARTAGE DE SERINGUE ; USAGER ; EVALUATION ; EFFICACITE ; PRODUIT ILLICITE
Domaine :	Drogues illicites / Illicit drugs
Discipline :	PRE Prévention / Prevention
Résumé :	Background: Harm reduction (HR) interventions are essential to reduce human immunodeficiency virus (HIV) and hepatitis C virus (HCV) transmission in people who inject drugs (PWID). Preliminary testing of the Individually Tailored Support and Education for Safer Injection (ITSESI) evidence-based educational intervention for PWID was performed in France in 2011. We created the Eurosider project to implement and evaluate ITSESI at a wider European level, with a view to its future pan-European diffusion. Methods: We performed a mixed-methods study involving quantitative (a 6-month before-after study with PWID) and qualitative (focus groups with field workers) components. The study was conducted in 2018-2019 with 307 eligible PWID participating in four existing HR programmes in Bulgaria, Greece, Portugal, and Romania. ITSESI consists in trained field workers observing PWID injection practices and providing an educational exchange. For the present study, PWID participants were allocated to either the control group (i.e., they continued receiving only the current HR services) or the intervention group (i.e., current HR services plus ITSESI). We used the RE-AIM QuEST framework to assess the effectiveness of ITSESI and its acceptability by field workers. Effectiveness was defined as a reduction in both syringe sharing - the highest HIV/HCV transmission risk practice - and in cutaneous abscesses. We used a multivariable mixed logit model to analyse both effectiveness outcomes and to provide adjusted odds ratios (aOR) and 95% confidence intervals (CI). Field workers' acceptability of the intervention was described using a thematic analysis of the qualitative data. Results: Of the 307 PWID, 55% received ITSESI. Syringe sharing and cutaneous abscesses decreased during follow-up in the intervention group (from 25 to 16% and from 27 to 14%, respectively). Reductions were smaller in the control group (from 29 to 24% and from 23 to 18%, respectively). The multivariable analyses confirmed the effect of the intervention on both of these outcomes (aOR [95% CI]: 0.38 [0.17, 0.85]) and (aOR [95% CI]: 0.38 [0.16, 0.90], respectively). Our qualitative data on acceptability showed the feasibility of involving field workers as proactive research partners in making ITSESI more accessible and acceptable across Europe. Conclusions: We demonstrated both the effectiveness of ITSESI in reducing syringe sharing and cutaneous abscesses in four European countries, and a high level of intervention acceptability by field workers. Our findings provide important insights into how ITSESI can be adapted for pan-European implementation. Highlights: • The Individually Tailored Support and Education for Safer Injection (ITSESI) intervention helps reduce both the HIV/HCV transmission risk practice of syringe sharing and cutaneous abscesses in PWID. • The implementation of an educational intervention for people who inject drugs (PWID) is feasible in the European context, provided that access to needle and syringe programmes and financial means for human resources are guaranteed. • Harm reduction interventions must be adapted to local drug policy contexts in order to avoid harms related to repression. • The use of mixed-methods and community-based participatory approaches ensures more efficient implementation and evaluation of the ITSESI.
Affiliation :	Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Marseille, France
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83590

[article] Implementation and evaluation of an educational intervention for safer injection in people who inject drugs in Europe: a multi-country mixed-methods study [Périodique] / P. ROUX ; C. DONADILLE ; C. MAGEN ; E. SCHATZ ; R. STRANZ ; A. CURADO ; T. TSIAKOU ; L. VERDES ; A. ALEKSOVA ; P. CARRIERI ; S. MEZAACHE ; A. BEN CHARIF . - 2021 . - art. 102992.
Langues : Anglais (eng)
in International Journal of Drug Policy > Vol.87 (January 2021) . - art. 102992

Mots-clés :	Thésaurus Géographique EUROPE ; BULGARIE ; GRECE ; PORTUGAL ; ROUMANIE Thésaurus TOXIBASE INJECTION ; INTERVENTION ; REDUCTION DES RISQUES ; EDUCATION POUR LA SANTE ; PARTAGE DE SERINGUE ; USAGER ; EVALUATION ; EFFICACITE ; PRODUIT ILLICITE
Domaine :	Drogues illicites / Illicit drugs
Discipline :	PRE Prévention / Prevention
Résumé :	Background: Harm reduction (HR) interventions are essential to reduce human immunodeficiency virus (HIV) and hepatitis C virus (HCV) transmission in people who inject drugs (PWID). Preliminary testing of the Individually Tailored Support and Education for Safer Injection (ITSESI) evidence-based educational intervention for PWID was performed in France in 2011. We created the Eurosider project to implement and evaluate ITSESI at a wider European level, with a view to its future pan-European diffusion. Methods: We performed a mixed-methods study involving quantitative (a 6-month before-after study with PWID) and qualitative (focus groups with field workers) components. The study was conducted in 2018-2019 with 307 eligible PWID participating in four existing HR programmes in Bulgaria, Greece, Portugal, and Romania. ITSESI consists in trained field workers observing PWID injection practices and providing an educational exchange. For the present study, PWID participants were allocated to either the control group (i.e., they continued receiving only the current HR services) or the intervention group (i.e., current HR services plus ITSESI). We used the RE-AIM QuEST framework to assess the effectiveness of ITSESI and its acceptability by field workers. Effectiveness was defined as a reduction in both syringe sharing - the highest HIV/HCV transmission risk practice - and in cutaneous abscesses. We used a multivariable mixed logit model to analyse both effectiveness outcomes and to provide adjusted odds ratios (aOR) and 95% confidence intervals (CI). Field workers' acceptability of the intervention was described using a thematic analysis of the qualitative data. Results: Of the 307 PWID, 55% received ITSESI. Syringe sharing and cutaneous abscesses decreased during follow-up in the intervention group (from 25 to 16% and from 27 to 14%, respectively). Reductions were smaller in the control group (from 29 to 24% and from 23 to 18%, respectively). The multivariable analyses confirmed the effect of the intervention on both of these outcomes (aOR [95% CI]: 0.38 [0.17, 0.85]) and (aOR [95% CI]: 0.38 [0.16, 0.90], respectively). Our qualitative data on acceptability showed the feasibility of involving field workers as proactive research partners in making ITSESI more accessible and acceptable across Europe. Conclusions: We demonstrated both the effectiveness of ITSESI in reducing syringe sharing and cutaneous abscesses in four European countries, and a high level of intervention acceptability by field workers. Our findings provide important insights into how ITSESI can be adapted for pan-European implementation. Highlights: • The Individually Tailored Support and Education for Safer Injection (ITSESI) intervention helps reduce both the HIV/HCV transmission risk practice of syringe sharing and cutaneous abscesses in PWID. • The implementation of an educational intervention for people who inject drugs (PWID) is feasible in the European context, provided that access to needle and syringe programmes and financial means for human resources are guaranteed. • Harm reduction interventions must be adapted to local drug policy contexts in order to avoid harms related to repression. • The use of mixed-methods and community-based participatory approaches ensures more efficient implementation and evaluation of the ITSESI.
Affiliation :	Aix Marseille Univ, INSERM, IRD, SESSTIM, Sciences Economiques and Sociales de la Santé and Traitement de l'Information Médicale, Marseille, France
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83590

[article] 
inInternational Journal of Drug Policy > Vol.87 (January 2021) . - art. 103014

Titre :	Making legitimacy: Drug user representation in United Nations drug policy settings
Type de document :	Périodique
Auteurs :	A. MADDEN ; K. LANCASTER ; A. RITTER ; C. TRELOAR
Année de publication :	2021
Article en page(s) :	art. 103014
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique INTERNATIONAL Organismes ONU Thésaurus TOXIBASE USAGER ; REPRESENTATION SOCIALE ; POLITIQUE ; DISCOURS
Domaine :	Drogues illicites / Illicit drugs
Discipline :	SHS Sciences humaines et sociales / Humanities and social sciences
Résumé :	Background: The importance of engaging people who use drugs in drug policy development is increasingly acknowledged including in recent UN documents. Little scholarly attention has been paid to 'drug user representation' in the global drug policy setting of the UN such as the Commission on Narcotic Drugs (CND). This paper examines 'drug user representation' in key UN drug policy processes over three decades. Method: A mapping process was undertaken using a corpus of publicly available documents from the UNGASS on Drugs and associated CND processes to identify relevant policy processes from 1987 to 2019 (n = 15) which were then assess for presence/absence of 'drug user representation'. Those processes with positive evidence of 'drug user representation' (n = 9) were critically interrogated across three co-constitutive domains of the subjects, objects and forms of 'drug user representation'. Results: Our analysis shows that despite calls for greater involvement, dominant UN drug policy discourses and other practices delimit both the political subjectivities available to people who use/have used drugs and their capacity to bring their voices to bear in this context. The analysis also highlights that human rights-based discourses, employed by 'drug user representatives', have emerged as an important practice of resistance against the problematic and delimiting power effects of existing UN discourses, governing practices and modes of engagement. Conclusions: In addition to the practices of resistance being undertaken by 'drug user representatives', we suggest there is a need to improve how 'drug user representation' is being made possible and done in the sites of UN drug policy deliberation and, that these sites should be opened for questioning. This we argue will not only have a positive impact on political legitimacy for 'drug user representation', but on the health and human rights of people who use/have used drugs. Highlights: • Recent commitments to greater involvement of people who use drugs in UN drug policy processes is a positive development but little research attention has been paid to 'drug user representation' in this context. • This paper examines 'drug user representation' in the UNGASS on drugs and associated CND processes over three decades. • Findings show that dominant UN drug policy discourses and other practices can have delimiting effects for the political legitimacy of drug user representatives. • Human rights-based discourses have emerged as an important site of resistance against these delimiting effects. • Opening existing UN discourses and other practices to questioning is important to improve how drug user representation is being made possible and done in the sites of UN drug policy deliberation.
Affiliation :	Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83592

[article] Making legitimacy: Drug user representation in United Nations drug policy settings [Périodique] / A. MADDEN ; K. LANCASTER ; A. RITTER ; C. TRELOAR . - 2021 . - art. 103014.
Langues : Anglais (eng)
in International Journal of Drug Policy > Vol.87 (January 2021) . - art. 103014

Mots-clés :	Thésaurus Géographique INTERNATIONAL Organismes ONU Thésaurus TOXIBASE USAGER ; REPRESENTATION SOCIALE ; POLITIQUE ; DISCOURS
Domaine :	Drogues illicites / Illicit drugs
Discipline :	SHS Sciences humaines et sociales / Humanities and social sciences
Résumé :	Background: The importance of engaging people who use drugs in drug policy development is increasingly acknowledged including in recent UN documents. Little scholarly attention has been paid to 'drug user representation' in the global drug policy setting of the UN such as the Commission on Narcotic Drugs (CND). This paper examines 'drug user representation' in key UN drug policy processes over three decades. Method: A mapping process was undertaken using a corpus of publicly available documents from the UNGASS on Drugs and associated CND processes to identify relevant policy processes from 1987 to 2019 (n = 15) which were then assess for presence/absence of 'drug user representation'. Those processes with positive evidence of 'drug user representation' (n = 9) were critically interrogated across three co-constitutive domains of the subjects, objects and forms of 'drug user representation'. Results: Our analysis shows that despite calls for greater involvement, dominant UN drug policy discourses and other practices delimit both the political subjectivities available to people who use/have used drugs and their capacity to bring their voices to bear in this context. The analysis also highlights that human rights-based discourses, employed by 'drug user representatives', have emerged as an important practice of resistance against the problematic and delimiting power effects of existing UN discourses, governing practices and modes of engagement. Conclusions: In addition to the practices of resistance being undertaken by 'drug user representatives', we suggest there is a need to improve how 'drug user representation' is being made possible and done in the sites of UN drug policy deliberation and, that these sites should be opened for questioning. This we argue will not only have a positive impact on political legitimacy for 'drug user representation', but on the health and human rights of people who use/have used drugs. Highlights: • Recent commitments to greater involvement of people who use drugs in UN drug policy processes is a positive development but little research attention has been paid to 'drug user representation' in this context. • This paper examines 'drug user representation' in the UNGASS on drugs and associated CND processes over three decades. • Findings show that dominant UN drug policy discourses and other practices can have delimiting effects for the political legitimacy of drug user representatives. • Human rights-based discourses have emerged as an important site of resistance against these delimiting effects. • Opening existing UN discourses and other practices to questioning is important to improve how drug user representation is being made possible and done in the sites of UN drug policy deliberation.
Affiliation :	Centre for Social Research in Health, University of New South Wales, Sydney, NSW, Australia
Cote :	Abonnement
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83592

[article] 
inDrug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108410

Titre :	Students' stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation
Type de document :	Périodique
Auteurs :	K. PONNET ; R. THOLEN ; S. DE BRUYN ; E. WOUTERS ; J. VAN OUYTSEL ; M. WALRAVE ; G. VAN HAL
Année de publication :	2021
Article en page(s) :	art. 108410
Langues :	Anglais (eng)
Mots-clés :	Thésaurus Géographique BELGIQUE Thésaurus TOXIBASE MILIEU ETUDIANT ; STIMULANTS ; PERFORMANCE ; JEUNE ; SEXE ; MEDICAMENTS ; USAGE DETOURNE ; ATTITUDE ; MODELE ; METHYLPHENIDATE ; NORME ; FACTEUR PREDICTIF
Domaine :	Autres substances / Other substances
Discipline :	SHS Sciences humaines et sociales / Humanities and social sciences
Résumé :	Background: Prescription stimulants such as methylphenidate are usually prescribed to treat attention deficit (and hyperactivity) disorders (ADHD). Recently, these drugs have gained popularity among college students, because of the belief that they can help improve academic performance. Objectives: This study assessed whether engaging in nonmedical use of prescription stimulants for cognitive enhancement is a rational or a more spontaneous decision-making process. Method: A survey was conducted among 661 students (63.5% females, n = 420, Mage = 21.40). Data were analyzed using structural equation modeling. Results: A total of 15.9% (n = 105) of the students had previously taken stimulants to improve their academic performance. The use of stimulants was significantly higher among males (22.4%) than females (12.1%). Positive attitudes toward stimulant use for cognitive enhancement were strongest related to students’ intention to take stimulants for increasing their academic performance, followed by the norm of parents. Additionally, the more the students identified themselves with the prototype of a student using stimulants for cognitive enhancement, the more likely they were to be willing to misuse stimulants. Conclusions: The findings suggest that using stimulants for cognitive enhancement is a rational choice rather than an unplanned one. Highlights: • Students' use of stimulants for enhancing academic performance is mainly the result of rational decision-making. • Students' attitude toward stimulant use for cognitive enhancement and the norm of the parents are strong predictors. • Similarity is positively related with the willingness to take stimulants for enhancing academic performance. • There are significant differences between male and female students with regard to stimulant use.
Affiliation :	Faculty of Social Sciences, Department of Communication Sciences, imec-mict-Ghent University, Ghent, Belgium
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305755
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83564

[article] Students' stimulant use for cognitive enhancement: A deliberate choice rather than an emotional response to a given situation [Périodique] / K. PONNET ; R. THOLEN ; S. DE BRUYN ; E. WOUTERS ; J. VAN OUYTSEL ; M. WALRAVE ; G. VAN HAL . - 2021 . - art. 108410.
Langues : Anglais (eng)
in Drug and Alcohol Dependence > Vol.218 (January 2021) . - art. 108410

Mots-clés :	Thésaurus Géographique BELGIQUE Thésaurus TOXIBASE MILIEU ETUDIANT ; STIMULANTS ; PERFORMANCE ; JEUNE ; SEXE ; MEDICAMENTS ; USAGE DETOURNE ; ATTITUDE ; MODELE ; METHYLPHENIDATE ; NORME ; FACTEUR PREDICTIF
Domaine :	Autres substances / Other substances
Discipline :	SHS Sciences humaines et sociales / Humanities and social sciences
Résumé :	Background: Prescription stimulants such as methylphenidate are usually prescribed to treat attention deficit (and hyperactivity) disorders (ADHD). Recently, these drugs have gained popularity among college students, because of the belief that they can help improve academic performance. Objectives: This study assessed whether engaging in nonmedical use of prescription stimulants for cognitive enhancement is a rational or a more spontaneous decision-making process. Method: A survey was conducted among 661 students (63.5% females, n = 420, Mage = 21.40). Data were analyzed using structural equation modeling. Results: A total of 15.9% (n = 105) of the students had previously taken stimulants to improve their academic performance. The use of stimulants was significantly higher among males (22.4%) than females (12.1%). Positive attitudes toward stimulant use for cognitive enhancement were strongest related to students’ intention to take stimulants for increasing their academic performance, followed by the norm of parents. Additionally, the more the students identified themselves with the prototype of a student using stimulants for cognitive enhancement, the more likely they were to be willing to misuse stimulants. Conclusions: The findings suggest that using stimulants for cognitive enhancement is a rational choice rather than an unplanned one. Highlights: • Students' use of stimulants for enhancing academic performance is mainly the result of rational decision-making. • Students' attitude toward stimulant use for cognitive enhancement and the norm of the parents are strong predictors. • Similarity is positively related with the willingness to take stimulants for enhancing academic performance. • There are significant differences between male and female students with regard to stimulant use.
Affiliation :	Faculty of Social Sciences, Department of Communication Sciences, imec-mict-Ghent University, Ghent, Belgium
Lien :	http://www.sciencedirect.com/science/article/pii/S0376871620305755
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83564

[article] 
inBulletin Epidémiologique Hebdomadaire > n°1 (5 janvier 2021) . - 11-17

Titre :	Tabac et maladies cardiovasculaires : le point sur la connaissance des Français, Baromètre de Santé publique France 2019
Titre traduit :	(French knowledge on tobacco and cardiovascular diseases, Santé publique France Health Barometer 2019)
Type de document :	Périodique
Auteurs :	V. OLIÉ ; M. HOUOT ; N. SOULLIER ; J. B. RICHARD ; A. GAUTIER ; V. NGUYEN-THANH ; A. PASQUEREAU ; C. GRAVE ; A. GABET ; D. THOMAS ; C. BONALDI
Année de publication :	2021
Article en page(s) :	11-17
Langues :	Français (fre)
Mots-clés :	Thésaurus Géographique FRANCE Organismes SANTE PUBLIQUE FRANCE Thésaurus TOXIBASE TABAC ; APPAREIL CARDIOVASCULAIRE ; NIVEAU DE CONNAISSANCES ; MORBIDITE ; FACTEUR DE RISQUE
Mots-clés :	Baromètre santé
Domaine :	Tabac / Tobacco
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	FRANÇAIS : Contexte - Le tabagisme constitue l'un des principaux facteurs de risque de maladies cardiovasculaires avec des effets pouvant être précoces et pour une très faible consommation de tabac. L'objectif de notre étude était de fournir un état des lieux de la connaissance, par la population, du tabac comme facteur de risque de maladies cardiovasculaires en 2019. Méthode - Notre étude a été réalisée à partir des données du Baromètre de Santé publique France 2019, enquête téléphonique réalisée auprès d'adultes âgés de 18 à 85 ans résidant en France métropolitaine. La connaissance de la population a été évaluée à partir de trois questions portant sur le tabac comme facteur de risque de maladies cardiovasculaires et les seuils de quantité de tabac et de durée de tabagisme à atteindre pour être à risque pour ces pathologies. Ces questions ont été posées à un sous-échantillon aléatoire de 5 074 personnes. Pour tenir compte du mode de recrutement des participants et que les données soient représentatives de la population de France métropolitaine, celles-ci ont été pondérées puis redressées sur la structure de la population (sexe, âge, niveau de diplôme, région, niveau d'urbanisation, taille du foyer). Résultats - En 2019, 9 Français sur 10 déclaraient que le tabac constituait un facteur de risque de maladies cardiovasculaires ou d'AVC. Seulement deux tiers avaient connaissance du risque cardiovasculaire pour une consommation de moins de 10 cigarettes par jour et 1 personne sur 4 avait connaissance d'un risque cardiovasculaire augmenté de manière immédiate chez les fumeurs. Les personnes de moins de 65 ans et celles avec un niveau de diplôme élevé avaient une meilleure connaissance du lien entre tabac et maladies cardiovasculaires et notamment des seuils de quantité et de durée pour être à risque. Conclusion - Cette étude met en évidence une amélioration importante, ces 20 dernières années, de la connaissance des Français sur le lien entre tabac et maladies cardiovasculaires. Néanmoins, cette connaissance reste très parcellaire, avec une sous-estimation par la population des seuils bas de dangerosité en quantité et en années de tabagisme. ENGLISH: Background - Smoking is one of the main risk factors for cardiovascular diseases with possible early impact for very low tobacco consumption. The objective of our study was to provide an overview of the knowledge of French people about tobacco as a risk factor for cardiovascular diseases in 2019. Method - Our study was carried out using data from Santé publique France Health Barometer 2019, a telephone survey carried out among adults, aged 18 to 85 years living in metropolitan France. Knowledge of French population was assessed on the basis of three questions on tobacco as a risk factor for cardiovascular diseases, the quantity of tobacco and the duration of smoking to be at risk for these pathologies. These questions were asked to a subsample of 5,074 people. To take into account the design of the survey and to ensure representatively of the population, data were weighted and recalibrate to adjust to the French population structure (sex, age, education level, region, urbanization level, household size). Results - In 2019, 9 out of 10 French people declared that smoking was a risk factor for cardiovascular disease or stroke. Only two thirds were aware of the cardiovascular risk for consuming less than 10 cigarettes per day and 1 in 4 people were aware of the early cardiovascular risk in smokers. People under 65 and people with a high level of education had a better knowledge of the link between tobacco and cardiovascular diseases especially of the thresholds of quantity and duration to be at risk. Conclusion - This study highlights a significant improvement in the knowledge of the French on the link between tobacco and cardiovascular diseases over the past 20 years. Nevertheless, this knowledge remains incomplete, with low thresholds of risk in quantity and time of smoking which are underestimated by the population.
Refs biblio. :	28
Affiliation :	Santé publique France, Saint-Maurice ; Université Paris-VI-Sorbonne, AP-HP, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France
Lien :	http://beh.santepubliquefrance.fr/beh/2021/1/2021_1_2.html
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83584

[article] Tabac et maladies cardiovasculaires : le point sur la connaissance des Français, Baromètre de Santé publique France 2019 = (French knowledge on tobacco and cardiovascular diseases, Santé publique France Health Barometer 2019) [Périodique] / V. OLIÉ ; M. HOUOT ; N. SOULLIER ; J. B. RICHARD ; A. GAUTIER ; V. NGUYEN-THANH ; A. PASQUEREAU ; C. GRAVE ; A. GABET ; D. THOMAS ; C. BONALDI . - 2021 . - 11-17.
Langues : Français (fre)
in Bulletin Epidémiologique Hebdomadaire > n°1 (5 janvier 2021) . - 11-17

Mots-clés :	Thésaurus Géographique FRANCE Organismes SANTE PUBLIQUE FRANCE Thésaurus TOXIBASE TABAC ; APPAREIL CARDIOVASCULAIRE ; NIVEAU DE CONNAISSANCES ; MORBIDITE ; FACTEUR DE RISQUE
Mots-clés :	Baromètre santé
Domaine :	Tabac / Tobacco
Discipline :	EPI Epidémiologie / Epidemiology
Résumé :	FRANÇAIS : Contexte - Le tabagisme constitue l'un des principaux facteurs de risque de maladies cardiovasculaires avec des effets pouvant être précoces et pour une très faible consommation de tabac. L'objectif de notre étude était de fournir un état des lieux de la connaissance, par la population, du tabac comme facteur de risque de maladies cardiovasculaires en 2019. Méthode - Notre étude a été réalisée à partir des données du Baromètre de Santé publique France 2019, enquête téléphonique réalisée auprès d'adultes âgés de 18 à 85 ans résidant en France métropolitaine. La connaissance de la population a été évaluée à partir de trois questions portant sur le tabac comme facteur de risque de maladies cardiovasculaires et les seuils de quantité de tabac et de durée de tabagisme à atteindre pour être à risque pour ces pathologies. Ces questions ont été posées à un sous-échantillon aléatoire de 5 074 personnes. Pour tenir compte du mode de recrutement des participants et que les données soient représentatives de la population de France métropolitaine, celles-ci ont été pondérées puis redressées sur la structure de la population (sexe, âge, niveau de diplôme, région, niveau d'urbanisation, taille du foyer). Résultats - En 2019, 9 Français sur 10 déclaraient que le tabac constituait un facteur de risque de maladies cardiovasculaires ou d'AVC. Seulement deux tiers avaient connaissance du risque cardiovasculaire pour une consommation de moins de 10 cigarettes par jour et 1 personne sur 4 avait connaissance d'un risque cardiovasculaire augmenté de manière immédiate chez les fumeurs. Les personnes de moins de 65 ans et celles avec un niveau de diplôme élevé avaient une meilleure connaissance du lien entre tabac et maladies cardiovasculaires et notamment des seuils de quantité et de durée pour être à risque. Conclusion - Cette étude met en évidence une amélioration importante, ces 20 dernières années, de la connaissance des Français sur le lien entre tabac et maladies cardiovasculaires. Néanmoins, cette connaissance reste très parcellaire, avec une sous-estimation par la population des seuils bas de dangerosité en quantité et en années de tabagisme. ENGLISH: Background - Smoking is one of the main risk factors for cardiovascular diseases with possible early impact for very low tobacco consumption. The objective of our study was to provide an overview of the knowledge of French people about tobacco as a risk factor for cardiovascular diseases in 2019. Method - Our study was carried out using data from Santé publique France Health Barometer 2019, a telephone survey carried out among adults, aged 18 to 85 years living in metropolitan France. Knowledge of French population was assessed on the basis of three questions on tobacco as a risk factor for cardiovascular diseases, the quantity of tobacco and the duration of smoking to be at risk for these pathologies. These questions were asked to a subsample of 5,074 people. To take into account the design of the survey and to ensure representatively of the population, data were weighted and recalibrate to adjust to the French population structure (sex, age, education level, region, urbanization level, household size). Results - In 2019, 9 out of 10 French people declared that smoking was a risk factor for cardiovascular disease or stroke. Only two thirds were aware of the cardiovascular risk for consuming less than 10 cigarettes per day and 1 in 4 people were aware of the early cardiovascular risk in smokers. People under 65 and people with a high level of education had a better knowledge of the link between tobacco and cardiovascular diseases especially of the thresholds of quantity and duration to be at risk. Conclusion - This study highlights a significant improvement in the knowledge of the French on the link between tobacco and cardiovascular diseases over the past 20 years. Nevertheless, this knowledge remains incomplete, with low thresholds of risk in quantity and time of smoking which are underestimated by the population.
Refs biblio. :	28
Affiliation :	Santé publique France, Saint-Maurice ; Université Paris-VI-Sorbonne, AP-HP, Institut de Cardiologie, Hôpital Pitié-Salpêtrière, Paris, France
Lien :	http://beh.santepubliquefrance.fr/beh/2021/1/2021_1_2.html
Permalink :	https://bdoc.ofdt.fr/index.php?lvl=notice_display&id=83584